Published On: Wed, Oct 19th, 2016

Kindred Healthcare, Inc. (NYSE:KND) Latest Broker Views


A number of investment brokers have recently updated their price targets on shares of Kindred Healthcare, Inc. (NYSE:KND).

Most recent broker ratings

08/09/2016 – Kindred Healthcare, Inc. had its “neutral” rating reiterated by analysts at UBS. They now have a USD 12.5 price target on the stock.

07/06/2016 – Kindred Healthcare, Inc. had its “neutral” rating reiterated by analysts at Mizuho. They now have a USD 11 price target on the stock.

06/17/2016 – Kindred Healthcare, Inc. had its “market perform” rating reiterated by analysts at Avondale Partners. They now have a USD 14 price target on the stock.

03/28/2016 – Kindred Healthcare, Inc. had its “market perform” rating reiterated by analysts at BMO Capital Markets.

03/07/2016 – Kindred Healthcare, Inc. had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 16 price target on the stock.

02/29/2016 – Kindred Healthcare, Inc. had its “overweight” rating reiterated by analysts at Barclays. They now have a USD 17 price target on the stock.

12/22/2015 – Kindred Healthcare, Inc. had its “neutral” rating reiterated by analysts at JP Morgan. They now have a USD 13 price target on the stock.

11/05/2015 – Kindred Healthcare, Inc. was downgraded to “market perform” by analysts at Wells Fargo.

05/01/2015 – Kindred Healthcare, Inc. was upgraded to “hold” by analysts at Zacks.

03/06/2015 – Deutsche Bank began new coverage on Kindred Healthcare, Inc. giving the company a “buy” rating. They now have a USD 30 price target on the stock.

03/05/2015 – Kindred Healthcare, Inc. had its “neutral” rating reiterated by analysts at Citigroup. They now have a USD 26 price target on the stock.

05/23/2014 – Craig-Hallum began new coverage on Kindred Healthcare, Inc. giving the company a “buy” rating. They now have a USD 25 price target on the stock.

05/09/2014 – Kindred Healthcare, Inc. had its “positive” rating reiterated by analysts at Susquehanna. They now have a USD 27 price target on the stock.

01/06/2014 – Guggenheim began new coverage on Kindred Healthcare, Inc. giving the company a “buy” rating.

The share price of Kindred Healthcare, Inc. (NYSE:KND) was up +4.97% during the last day of trading, with a day high of 10.05. 920047 shares were traded during the last session.

The stock’s 50 day moving average is 10.23 and its 200 day moving average is 11.65. The stock’s market capitalization is 846.56M. Kindred Healthcare, Inc. has a 52-week low of 7.96 and a 52-week high of 15.66.

Kindred Healthcare, Inc. is a healthcare services company. The Company operates through four divisions, including the hospital division, the Kindred at Home division, the Kindred Rehabilitation Services division and the nursing center division. Its divisions represent over six segments, including hospitals, home health services, hospice services, Kindred Hospital Rehabilitation Services, RehabCare and nursing centers. The Company’s hospital division provides long-term acute care services through the operation of a national network of approximately 95 transitional care (TC) hospitals. Its Kindred at Home division provides home health, hospice, and community care services. Its Kindred Rehabilitation Services division operates inpatient rehabilitation hospitals (IRFs) and acute rehabilitation units (ARUs), and provides rehabilitation services. Its nursing center division provides care through the operation of a national network of approximately 90 nursing centers.